Ka Chung Tong

Title: Innovations in Cancer Treatment by Ka Chung Tong

Introduction

Ka Chung Tong is a notable inventor based in Hong Kong, CN. He has made significant contributions to the field of cancer treatment through his innovative research and development of Iridium (III) complexes. His work focuses on the synthesis and application of these complexes in combating cancer.

Latest Patents

Ka Chung Tong holds a patent for "Iridium (III) complexes containing N-heterocyclic carbene ligand, synthesis, and their use thereof in cancer treatment." This patent outlines the composition of Ir(III) complexes that include N-heterocyclic carbene ligands. It details methods for synthesizing these complexes and their pharmaceutical applications. The patent also describes methods for treating and preventing cancer in patients through the administration of these complexes under various conditions. The Ir(III) complexes demonstrate anticancer properties, including the induction of cell death, inhibition of cellular proliferation, and suppression of tumor growth in vivo.

Career Highlights

Ka Chung Tong is affiliated with The University of Hong Kong, where he conducts his research. His work has garnered attention for its potential impact on cancer therapies. He has successfully developed a method for detecting the Ir(III) complex in biological systems, further enhancing the applicability of his inventions in medical settings.

Collaborations

Ka Chung Tong collaborates with esteemed colleagues, including Chi Ming Che and Tsz Lung Lam. Their combined expertise contributes to the advancement of research in the field of cancer treatment.

Conclusion

Ka Chung Tong's innovative work in developing Iridium (III) complexes represents a significant advancement in cancer treatment. His contributions have the potential to improve therapeutic outcomes for patients battling cancer.